DGAP-News: Gerresheimer AG / Key word(s): Quarterly / Interim Statement/Half Year Report 13.07.2021 / 07:00 The issuer is solely responsible for the content of this announcement.
Gerresheimer accelerates revenue growth
Organic Group revenue growth of 7.5 %, and 7.1 % in core business
Solutions for biotech drugs and high-value solutions continue to drive revenues increase
Organic adjusted EBITDA margin at 22.8 % in core business
Adjusted earnings per share up organically by 19.1 % to EUR 1.28
Guidance confirmed for the financial year 2021
Duesseldorf, July 13, 2021 - Gerresheimer AG showed strong revenue growth in the second quarter of 2021. "The new company focus on sustainable growth, innovation and providing solutions for our customers is bearing fruits. We revealed our strengths in the second quarter. Prefillable syringes and other high-value solutions such as for biotech drugs are the main drivers. The delivery of injection vials is running as planned. We expect a strong second half of the year and confirm our guidance for 2021," says Dietmar Siemssen, CEO of Gerresheimer AG.
In the second quarter of 2021, Gerresheimer AG generated organic Group revenues of EUR 377m. Revenues increased organically by 7.5 %, with revenues in the core business growing by 7.1 % year on year. The Plastics & Devices Division recorded organic growth of 4.4 % in the second quarter of 2021. The company achieved considerable growth in revenues in pharmaceutical primary packaging solutions made of plastic and in the syringes business in particular. Organic revenues in the Primary Packaging Glass Division rose by 10.3 % year on year. Significant revenue increases were recorded for high-value solutions in particular, such as Elite Glass products.
Adjusted EBITDA in the core business stood at EUR 85 million, corresponding to an organic growth of 3.1 %. The organic adjusted EBITDA margin in the core business amounted to 22.8 %. Adjusted net income stood at EUR 41 million. Adjusted earnings per share stood at EUR 1.28, which is a year-on-year increase of 19.1 %.
Forecast
Outlook for the financial year 2021 (core business, currency adjusted):
Revenue growth in the mid-single-digit percentage range
Adjusted EBITDA margin between 22 % and 23 %
Adjusted earnings per share to improve by around 10 %
Medium term (core business, net of currency effects):
Revenue growth in the high single-digit percentage range
Adjusted EBITDA margin of around 23 %
Adjusted earnings per share to improve by at least 10 % per year
The Quarterly Statement for the second quarter of 2021 is available here: https://www.gerresheimer.com/en/company/investor-relations/reports
Press contact Jens Kürten Group Senior Director Communication & Marketing T +49 211 6181-250 jens.kuerten@gerresheimer.com
Investor Relations contact Carolin Nadilo Corporate Director Investor Relations T +49 211 6181-220 carolin.nadilo@gerresheimer.com
About Gerresheimer Gerresheimer is the global partner for pharma, biotech, healthcare and cosmetics with a very broad product range for pharmaceutical and cosmetic packaging and drug delivery devices. The company is an innovative solution provider from concept to delivery of the end product. Gerresheimer achieves its ambitious goals through a high level of innovative strength, industrial competence, focus on quality and customers. In developing innovative and sustainable solutions, Gerresheimer relies on a comprehensive international network with numerous innovation and production centers in Europe, America and Asia. Gerresheimer produces close to its customers worldwide with around 10,000 employees and generates annual sales of more than €1.4 billion. With its products and solutions, Gerresheimer plays an essential role in people's health and well-being.
Key Figures for the Gerresheimer Group
x
13.07.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de
Language:
English
Company:
Gerresheimer AG
Klaus-Bungert-Str. 4
40468 Düsseldorf
Germany
Phone:
+49-(0)211/61 81-314
Fax:
+49-(0)211/61 81-121
E-mail:
carolin.nadilo@gerresheimer.com
Internet:
http://www.gerresheimer.com
ISIN:
DE000A0LD6E6
WKN:
A0LD6E
Indices:
MDAX (Aktie)
Listed:
Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID:
1218009
End of News
DGAP News Service
show this
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting
The ultimate “DAO operating system” solution for DAO creation and management, The Summon Platform, shows strong momentum since announcement three weeks ago. Next week, the platform’s crucial utility/governance token will be distributed to community members encouraging their active participation in development priorities.ZUG, Switzerland, Aug. 11, 2022 (GLOBE NEWSWIRE) -- The Summon Platform, a comprehensive “operating system” for groups and organizations to easily create and manage Decentralized
Writing in The Times, he said every household would get savings of around 200 pounds ($244) on their energy bills with a reduction in value-added tax (VAT). The UK is bracing for already high energy bills to more than triple this year, with charities warning that millions of people could be forced into poverty if the government does not launch a multi-billion pound support package to soften the blow. Sunak, an underdog in the leadership race behind front-runner Liz Truss, said his plan would cover "support for the most vulnerable, support for pensioners and some support for everyone."
Biopharmaceutical companies rely on contract manufacturing organizations (CMOs) to provide capabilities and skills as needed. The CMO has provided most of the company’s production in some cases.New York, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Biopharmaceutical Contract Manufacturing Market – Global Outlook & Forecast 2022-2027" - https://www.reportlinker.com/p06313593/?utm_source=GNW The market is mainly growing owing to the uptake of branded biol
A hot, dry July made worse by climate change has raised the risk that the German economy could run aground as sinking Rhine waters make shipping along the river harder.
Global Molecular Diagnostics Market Global Molecular Diagnostics Market Dublin, Aug. 11, 2022 (GLOBE NEWSWIRE) -- The "Molecular Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis" report has been added to ResearchAndMarkets.com's offering. The molecular diagnostics market is projected to grow from US$ 16,258.97 million in 2021 to US$ 36,176.65 million by 2028; it is expected to grow at a CAGR of 12.1% during 2021-2028. The market growth is mainly attributed to an increase
Venezuela has suspended new crude shipments to Europe under an oil-for-debt deal and has asked Italy's Eni and Spain's Repsol to provide it with fuel in exchange for future cargoes, three people familiar with the matter said. Venezuela's oil company PDVSA no longer is interested in the oil-for-debt deals that the U.S. State Department authorized in May, the sources said, which allowed the state company to resume shipments to Europe after a two-year suspension caused by U.S. sanctions. Washington authorized the shipments as long as cargo proceeds were used to pay off accumulated debt PDVSA owed to joint ventures with Eni and Repsol.
Stable Isotope Labeled Compounds Market Research Report by Type (Carbon-13, Deuterium, and Nitrogen-15), Application, End User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19New York, Aug. 12, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Stable Isotope Labeled Compounds Market Research Report by Type, Application, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-1
Letters: Prof Mike Stein and Peter Riddle on Labour’s policy void as Britain grapples with rising costs and inflation. Plus a stark warning by Dr Thomas Richardson on the heavy price people will pay in terms of mental health problems
Plant Extracts Market Research Report by Type (Essential Oils & Natural Extracts, Flavors & Fragrances, and Phytochemicals), Sources, Application, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19New York, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Plant Extracts Market Research Report by Type, Sources, Application, Region - Global Forecast to 2027 - Cumulative Impact of COVID-1
Diesel Common Rail Injection System Market Diesel Common Rail Injection System Market Dublin, Aug. 11, 2022 (GLOBE NEWSWIRE) -- The "Diesel Common Rail Injection System Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering. The global diesel common rail injection system market reached a value of US$ 3.36 Billion in 2021. Looking forward, the publisher expects the market to reach a value of US$ 4.17 Bill
Southeast Asian Automobile Market Southeast Asian Automobile Market Dublin, Aug. 11, 2022 (GLOBE NEWSWIRE) -- The "Research Report on the Automobile Industry in Southeast Asia, 2022-2031" report has been added to ResearchAndMarkets.com's offering. The development of the automobile industry differs greatly among the Southeast Asian countries. According to the analysis, Thailand is the most developed country in terms of automobile manufacturing. Some world's leading automobile manufacturers, such
A London home now costs just over £526,000 on average. Here’s what half a million pounds could buy you across London right now. In London’s cheapest borough, this three-bedroom semi-detached house has a living area that leads to a long, narrow rear garden.
To Nasdaq Copenhagen CORRECTION to Terms for Nykredit's and Totalkredit's auctions With reference to the terms for Nykredit's and Totalkredit's refinancing auctions published in a stock exchange announcement on 3 August 2022, we hereby publish changes to the volumes of two of the auctions in EUR. The changes are due to an internal error, and the correct volumes can be found in the included Appendix. All other terms remain unchanged. Questions may be addressed to Nykredit Realkredit A/S, Group Tr
United Kingdom Non-Invasive Prenatal Testing Market United Kingdom Non-Invasive Prenatal Testing Market Dublin, Aug. 11, 2022 (GLOBE NEWSWIRE) -- The "United Kingdom Non-Invasive Prenatal Testing Market and Forecasts 2022 - 2028" report has been added to ResearchAndMarkets.com's offering. The United Kingdom Non-Invasive Prenatal Testing Market was valued at $187 Million in 2021 and is estimated to reach a value of $481 Million by 2028 at a growth rate of 14.4%. This new market report presents a
China's top internet watchdog said on Friday tech giants such as Tencent Holdings and Alibaba Group have submitted details of algorithms used in some of their products, complying with a drive by authorities to tighten oversight of platform algorithms. The rules are part of a broad regulatory crackdown by Beijing against its once free-wheeling technology sector. State media had accused internet platforms of using algorithms to invade user privacy and influencing their choices.
Yahoo Finance
